• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Pharma USA 2023: Digital Therapeutics and Pharma

Article

Using prescription digital therapeutics can lead to better outcomes for patients, making them a win-win for pharma and patients.

Tracey Dodenhoff, CEO of Medly Therapeutics, discusses her company's heart failure app and why pharma should consider prescription digital therapeutics among their offerings.

Recent Videos
Related Content
Ryan Murphy

Validating COAs: Key Steps for Accurate and Reliable Clinical Trial Data

Ryan Murphy
September 5th 2024
Article

With the increasing adoption of COAs, the importance of standardization across training, collection, and implementation to ensure high quality and consistent data collection has become apparent in recent decades.

Cheryl Reicin

Understanding the Current State of M&A: Q&A with Cheryl Reicin

Mike Hollan
September 3rd 2024
Article

As the second half of 2024 begins, an industry expert discusses how mergers and acquisitions are trending in the pharma industry.

Jenny Denney

Embracing FSPs: Q&A with Jenny Denney

Mike Hollan
August 30th 2024
Article

Pharmaceutical companies are seeing the benefits of being able to outsource entire functions through functional service providers.

Revitalizing Mature Pharma Brands: 5 Winning Strategies

Revitalizing Mature Pharma Brands: 5 Winning Strategies

Sayali Kadam
August 30th 2024
Article

Strategies that can help maintain and grow your market share. Plus how to adapt to new competitive pressures and evolving customer needs.

Fulling and Cournoyer

A Case for Payer Engagement and Participation in Clinical Research

Doug Fulling;Andrew Cournoyer
August 27th 2024
Article

Collaboration can make commercialization processes efficient and effective.

Dan Rizzo

Targeted Pre-Launch Scientific Outreach: Q&A with Dan Rizzo

Mike Hollan
August 26th 2024
Article

Rizzo discusses Veeva’s latest findings on how life sciences companies are utilizing this strategy to speed up uptake of new treatments.